Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds

Currently, it is estimated that 1–2 million people worldwide are infected with HIV-2, accounting for 3–5% of the global burden of HIV. The course of HIV-2 infection is longer compared to HIV-1 infection, but without effective antiretroviral therapy (ART), a substantial proportion of infected patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Moranguinho, Inês, Taveira, Nuno, Bártolo, Inês
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053740/
https://www.ncbi.nlm.nih.gov/pubmed/36982978
http://dx.doi.org/10.3390/ijms24065905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053740/
https://www.ncbi.nlm.nih.gov/pubmed/36982978
http://dx.doi.org/10.3390/ijms24065905

Ejemplares similares